Skip to main content

Table 1 Key questions used to develop the Consensus Conference on iatrogenic colonoscopy perforation (ICP)

From: 2017 WSES guidelines for the management of iatrogenic colonoscopy perforation

Risk of ICP
 Q1 What are the general recommendations to minimize the risk of ICP during screening and therapeutic colonoscopies?
 Q2 What is the maximum incidence of ICP considered acceptable for centers where diagnostic or therapeutic colonoscopies are performed?
Diagnosis of ICP
 Q3 What is the minimum information the endoscopist must report after diagnosing an ICP during a colonoscopy procedure?
 Q4 What are the minimum biochemical and imaging investigations that should be requested in the case of suspected ICP?
Conservative and endoscopic treatments of ICP
 Q5 What are the indications for a conservative treatment or an immediate surgical intervention after an ICP diagnosis?
 Q6 What is the minimum duration of the hospital observation period for patients who have undergone successful endoscopic closure or conservative management of ICP?
 Q7 What investigations (clinical, biochemical, and imaging) should be performed during the observation period in patients who have undergone successful endoscopic closure or conservative management of ICP?
 Q8 What is the recommended type and duration of antibiotic therapy in patients who have undergone successful endoscopic closure or conservative management of ICP?
 Q9 What is the recommended type and duration of antithrombotic prophylaxis in patients who have undergone successful endoscopic closure or conservative management of ICP?
 Q10 How long is the fasting time in patients who have undergone successful endoscopic closure or conservative treatments for ICP?
Surgical treatment of ICP
 Q11 Is explorative laparoscopy indicated in all patients with ICP?
 Q12 What are the indications for conversion from laparoscopy to open surgery in patients with surgical ICP?
 Q13 What are the key factors when choosing the best surgical approach for ICP?
 Q14 What are the indications for performing a diverting or terminal stoma in patients with ICP?
 Q15 What are the indications for drainages in patients with ICP?
 Q16 What are the indications for the use of damage control surgery in patients with ICP?
Follow-up of ICP
 Q17 Is there any recommendation to perform a surveillance endoscopy after a successful ICP treatment? If so, what is the recommended timing for it?